Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation.
about
Immune Reconstitution after Allogeneic Hematopoietic Stem Cell TransplantationRapid generation of clinical-grade antiviral T cells: selection of suitable T-cell donors and GMP-compliant manufacturing of antiviral T cells.Use of Modeling and Simulation in the Design and Conduct of Pediatric Clinical Trials and the Optimization of Individualized Dosing Regimens.Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complicationsPredicting the Clinical Outcome of Allogeneic Hematopoietic Stem Cell Transplantation: The Long and Winding Road toward Validated Immune Biomarkers.Cellular immune therapy for viral infections in transplant patientsClinical pharmacokinetics and pharmacodynamics of ganciclovir and valganciclovir in children with cytomegalovirus infection.Complex correlates of protection after vaccination.The immune response to cytomegalovirus in allogeneic hematopoietic stem cell transplant recipients.Treatment of CMV infection after allogeneic hematopoietic stem cell transplantation.Cytomegalovirus in hematopoietic stem cell transplant recipients - management of infection.Strategies to control human cytomegalovirus infection in adult hematopoietic stem cell transplant recipients.Streptamer technology allows accurate and specific detection of CMV-specific HLA-A*02 CD8+ T cells by flow cytometry.CMV-specific immune reconstitution following allogeneic stem cell transplantation.Comparative Analysis of Clinical-Scale IFN-γ-Positive T-Cell Enrichment Using Partially and Fully Integrated Platforms.Reconstitution of cytomegalovirus-specific T-cell response in allogeneic hematopoietic stem cell recipients: the contribution of six frequently recognized, virus-encoded ORFs.Monitoring human cytomegalovirus infection in pediatric hematopoietic stem cell transplant recipients: using an affordable in-house qPCR assay for management of HCMV infection under limited resources.Polyfunctional analysis of human cytomegalovirus (HCMV)-specific CD4(+) and CD8 (+) memory T-cells in HCMV-seropositive healthy subjects following different stimuli.Functional specific-T-cell expansion after first cytomegalovirus reactivation predicts viremia control in allogeneic hematopoietic stem cell transplant recipients.Adoptive T-cell immunotherapy from third-party donors: characterization of donors and set up of a T-cell donor registry.Dynamics of Sendai virus spread, clearance, and immunotherapeutic efficacy after hematopoietic cell transplant imaged non-invasively in mice.Early recovery of CMV immunity after HLA-haploidentical hematopoietic stem cell transplantation as a surrogate biomarker for a reduced risk of severe infections overall.Cytomegalovirus induces HLA-class-II-restricted alloreactivity in an acute myeloid leukemia cell line.Appearance of cytomegalovirus-specific T-cells predicts fast resolution of viremia post hematopoietic stem cell transplantation.
P2860
Q28072627-D6891AFD-EEFD-4368-91A8-862BACDCBC02Q35104509-DAEC7DD6-A6A3-4CAD-B96C-92D8C2AA3411Q36473125-ED98B4A8-7E76-413D-AD5F-7F0EA73C25D3Q37227240-F8022CB2-8071-4727-B761-3E30B73B7155Q38093355-826F82CB-FA28-4AE1-82F8-7E0168422336Q38179174-5B52D1BF-0920-4492-9657-0656BD86E9BCQ38271850-0AFBECD8-7B26-4C33-A659-C2E438D79CC5Q38456515-F0481A16-66BF-452E-9EA0-8F60E6A80624Q38547042-0CBDAFDE-B554-4CE9-A430-57623869421DQ38797660-521B0761-FCE6-4F5B-9A8B-CEB7CB967956Q38802522-AE34118C-847F-44F4-AF7D-1069184010B1Q38835171-54B08E22-DDFA-4436-81EF-7AA8758EF082Q38902980-16359B1A-87BB-4CAD-9F8E-6403D59DAE4EQ38942459-E357AF56-16FF-4288-B792-1AE2C02C27D1Q40504861-8C31F4E6-737A-4F15-8372-B13D423CE1ECQ40809488-0D1C0E8E-7474-4910-98B0-B290759FD367Q41373726-AA21F2FB-059E-418D-BDAB-C1F3ABC4A287Q41735217-F3A34084-0A8D-42A0-B73A-BD38F74FB3FBQ41935471-F6E9E3B4-7DB9-4180-9762-8AC7527FDBFBQ42271011-B38FBAC6-2871-4B70-9B5D-97774B7D3EA3Q45325417-34AAE587-136E-42D3-BC43-6BDA3B57F7C3Q45876839-7471FD3B-DCF0-47DC-9316-92E1C2D98FA8Q47548299-F4CABCEF-4BD2-42BE-BD08-F1901F7170E7Q48905387-A660E432-9F5A-46CB-B27F-0CEC1B431A24
P2860
Monitoring of human cytomegalovirus and virus-specific T-cell response in young patients receiving allogeneic hematopoietic stem cell transplantation.
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Monitoring of human cytomegalo ...... tic stem cell transplantation.
@ast
Monitoring of human cytomegalo ...... tic stem cell transplantation.
@en
Monitoring of human cytomegalo ...... tic stem cell transplantation.
@nl
type
label
Monitoring of human cytomegalo ...... tic stem cell transplantation.
@ast
Monitoring of human cytomegalo ...... tic stem cell transplantation.
@en
Monitoring of human cytomegalo ...... tic stem cell transplantation.
@nl
prefLabel
Monitoring of human cytomegalo ...... tic stem cell transplantation.
@ast
Monitoring of human cytomegalo ...... tic stem cell transplantation.
@en
Monitoring of human cytomegalo ...... tic stem cell transplantation.
@nl
P2093
P2860
P1433
P1476
Monitoring of human cytomegalo ...... tic stem cell transplantation.
@en
P2093
Angela Mastronuzzi
Antonella Chiesa
Giovanna Giorgiani
Giuseppe Gerna
Marco Zecca
Paola Zelini
Vanina Rognoni
P2860
P304
P356
10.1371/JOURNAL.PONE.0041648
P407
P577
2012-07-25T00:00:00Z